Literature DB >> 33100049

Effects of Intensive Systolic Blood Pressure Control on All-Cause Hospitalizations.

Michael V Rocco1, Mary E Comeau2, Miranda C Marion2, Barry I Freedman1, Amret T Hawfield1, Carl D Langefeld2.   

Abstract

Intensive blood pressure control decreases the rate of cardiovascular events by >25% compared with standard blood pressure control. We sought to determine whether the decrease in cardiovascular events seen with intensive blood pressure control is associated with an increased rate of other causes of hospitalization. This is a post hoc analysis of SPRINT (Systolic Blood Pressure Intervention Trial) in 9361 adult participants with hypertension and elevated cardiovascular risk. Participants were randomly assigned to an intensive or standard systolic blood pressure goal (<120 or <140 mm Hg, respectively). The primary outcome was hospitalization rates per 100 person-years for hospitalizations not associated with SPRINT primary events. After excluding hospitalizations linked to SPRINT primary events, there were 4678 participants with a rate of 19.70 hospitalizations per 100 person-years, compared with 4683 participants with a rate of 19.65 (P=0.37). Equivalence testing shows that these hospitalization rates were statistically equivalent at the P=0.05 level. Of those with hospitalizations, >1 hospitalization was seen in 38.8% of intensive arm participants and 41.9% of standard arm participants (P=0.08). The mean cumulative count of nonprimary event hospitalizations was comparable between the two arms. The most common causes of hospitalization were cardiovascular (23.6%) followed by injuries, including bone and joint therapeutic procedures (15.7%), infections (12.0%), and nervous systems disorders (10.7%). No categories of hospitalization were statistically more common in the intensive arm compared with the standard arm. Thus, the decrease in cardiovascular events seen with intensive blood pressure control is not associated with an increased rate of other causes of hospitalization. Registration- URL: https://www.clinicaltrials.gov; Unique identifier: NCT01206062.

Entities:  

Keywords:  cardiovascular diseases; goals; hospitalization; hypertension; risk factors

Mesh:

Substances:

Year:  2020        PMID: 33100049      PMCID: PMC7666020          DOI: 10.1161/HYPERTENSIONAHA.120.15868

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  12 in total

1.  Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).

Authors:  Adam P Bress; Holly Kramer; Rasha Khatib; Srinivasan Beddhu; Alfred K Cheung; Rachel Hess; Vinod K Bansal; Guichan Cao; Jerry Yee; Andrew E Moran; Ramon Durazo-Arvizu; Paul Muntner; Richard S Cooper
Journal:  Circulation       Date:  2017-02-13       Impact factor: 29.690

2.  Estimating the burden of recurrent events in the presence of competing risks: the method of mean cumulative count.

Authors:  Huiru Dong; Leslie L Robison; Wendy M Leisenring; Leah J Martin; Gregory T Armstrong; Yutaka Yasui
Journal:  Am J Epidemiol       Date:  2015-02-17       Impact factor: 4.897

3.  The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT).

Authors:  Walter T Ambrosius; Kaycee M Sink; Capri G Foy; Dan R Berlowitz; Alfred K Cheung; William C Cushman; Lawrence J Fine; David C Goff; Karen C Johnson; Anthony A Killeen; Cora E Lewis; Suzanne Oparil; David M Reboussin; Michael V Rocco; Joni K Snyder; Jeff D Williamson; Jackson T Wright; Paul K Whelton
Journal:  Clin Trials       Date:  2014-06-05       Impact factor: 2.486

4.  A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability.

Authors:  D J Schuirmann
Journal:  J Pharmacokinet Biopharm       Date:  1987-12

Review 5.  Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.

Authors:  Dena Ettehad; Connor A Emdin; Amit Kiran; Simon G Anderson; Thomas Callender; Jonathan Emberson; John Chalmers; Anthony Rodgers; Kazem Rahimi
Journal:  Lancet       Date:  2015-12-24       Impact factor: 79.321

6.  Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis.

Authors:  Joshua D Bundy; Changwei Li; Patrick Stuchlik; Xiaoqing Bu; Tanika N Kelly; Katherine T Mills; Hua He; Jing Chen; Paul K Whelton; Jiang He
Journal:  JAMA Cardiol       Date:  2017-07-01       Impact factor: 14.676

7.  Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.

Authors:  Jeff D Williamson; Mark A Supiano; William B Applegate; Dan R Berlowitz; Ruth C Campbell; Glenn M Chertow; Larry J Fine; William E Haley; Amret T Hawfield; Joachim H Ix; Dalane W Kitzman; John B Kostis; Marie A Krousel-Wood; Lenore J Launer; Suzanne Oparil; Carlos J Rodriguez; Christianne L Roumie; Ronald I Shorr; Kaycee M Sink; Virginia G Wadley; Paul K Whelton; Jeffrey Whittle; Nancy F Woolard; Jackson T Wright; Nicholas M Pajewski
Journal:  JAMA       Date:  2016-06-28       Impact factor: 56.272

8.  Orthostatic Hypotension, Cardiovascular Outcomes, and Adverse Events: Results From SPRINT.

Authors:  Stephen P Juraschek; Addison A Taylor; Jackson T Wright; Gregory W Evans; Edgar R Miller; Timothy B Plante; William C Cushman; Tanya R Gure; William E Haley; Imran Moinuddin; John Nord; Suzanne Oparil; Carolyn Pedley; Christianne L Roumie; Jeff Whittle; Alan Wiggers; Ciarán Finucane; Rose Anne Kenny; Lawrence J Appel; Raymond R Townsend
Journal:  Hypertension       Date:  2020-01-27       Impact factor: 10.190

9.  Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT).

Authors:  Michael V Rocco; Kaycee M Sink; Laura C Lovato; Dawn F Wolfgram; Thomas B Wiegmann; Barry M Wall; Kausik Umanath; Frederic Rahbari-Oskoui; Anna C Porter; Roberto Pisoni; Cora E Lewis; Julia B Lewis; James P Lash; Lois A Katz; Amret T Hawfield; William E Haley; Barry I Freedman; Jamie P Dwyer; Paul E Drawz; Mirela Dobre; Alfred K Cheung; Ruth C Campbell; Udayan Bhatt; Srinivasan Beddhu; Paul L Kimmel; David M Reboussin; Glenn M Chertow
Journal:  Am J Kidney Dis       Date:  2017-11-20       Impact factor: 8.860

10.  A Short History of Automated Office Blood Pressure - 15 Years to SPRINT.

Authors:  Martin G Myers
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-04-01       Impact factor: 3.738

View more
  1 in total

Review 1.  Guideline-Driven Management of Hypertension: An Evidence-Based Update.

Authors:  Robert M Carey; Jackson T Wright; Sandra J Taler; Paul K Whelton
Journal:  Circ Res       Date:  2021-04-01       Impact factor: 17.367

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.